Daxor Corporation is an innovative medical instrumentation and biotechnology company focused on blood volume measurement. We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
View Our Story
Dozens of peer-reviewed studies have established the value of Daxor’s diagnostic, confirming that accurate blood volume measurement leads to better informed physicians, better treatment strategies, and improves patient outcomes and resource utilization.
Our mission is to partner with clinicians to incorporate BVA technology into standard clinical practice and improve the quality of life for patients.